Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Magnesium levels after magnesium-containing cathartics.

M J Smilkstein1, D Steedle, K W Kulig

  • 1Rocky Mountain Poison and Drug Center, Denver, Colorado.

Journal of Toxicology. Clinical Toxicology
|January 1, 1988
PubMed
Summary

This study examined how magnesium levels change after using magnesium-containing cathartics in patients with suspected drug overdose. Researchers compared two groups: one receiving a single dose and the other multiple doses of magnesium sulfate. They found that patients given multiple doses had significantly higher magnesium levels than those given a single dose. Some patients developed elevated magnesium levels even though their kidney function was normal. The study also found that patients who had ingested anticholinergic or opioid drugs had higher magnesium levels. These findings suggest that repeated use of magnesium-containing cathartics can lead to hypermagnesemia, even in patients with normal kidney function. The authors recommend caution when using multiple doses and suggest monitoring magnesium levels in such cases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Artificial intelligence for direct-to-physician reporting of ambulatory electrocardiography.

Nature medicine·2025
Same author

4-Methylpyrazole protects against acetaminophen hepatotoxicity in mice and in primary human hepatocytes.

Human & experimental toxicology·2018
Same author

A single-arm clinical trial of a 48-hour intravenous N-acetylcysteine protocol for treatment of acetaminophen poisoning.

Clinical toxicology (Philadelphia, Pa.)·2014
Same author

Treatment of pain or fever with paracetamol (acetaminophen) in the alcoholic patient: a systematic review.

American journal of therapeutics·2001
Same author

Who is at low risk after head or neck trauma?

The New England journal of medicine·2000
Same author

Value of point-of-care blood testing in emergent trauma management.

The Journal of trauma·2000

Area of Science:

  • Clinical toxicology
  • Pharmacology and drug overdose management
  • Electrolyte metabolism in emergency medicine

Background:

Serum magnesium levels are typically stable in most patients. Prior research has shown that magnesium-containing cathartics are commonly used in emergency settings. No prior work had resolved how repeated doses affect magnesium levels in overdose cases. It was already known that single-dose cathartics rarely cause significant changes. This gap motivated a closer look at multi-dose regimens. Some studies suggest that renal function influences magnesium retention. However, the exact impact of repeated dosing remains unclear. This paper's contribution is to track magnesium levels after multiple doses in overdose patients.

Purpose Of The Study:

The study aimed to assess how repeated oral magnesium sulfate doses affect serum magnesium levels in overdose patients. The specific problem is the potential for hypermagnesemia after multiple doses. The motivation comes from the lack of data on this scenario. Researchers wanted to compare single versus multiple dose effects. They focused on patients with normal renal function. The goal was to determine if standard doses could lead to elevated levels. The study also aimed to identify any drug-specific patterns. The findings could guide emergency cathartic use protocols.

Keywords:
magnesium cathartics overdoseserum magnesium levelsdrug overdose treatmentelectrolyte changes in emergency medicine

Frequently Asked Questions

Nine out of 14 patients developed elevated magnesium levels (2.2 to 5.0 mEq/L) after multiple doses of magnesium sulfate.

Levels were measured before each dose and 1 and 4 hours after the final dose in both single and multiple dose groups.

These patients had higher peak magnesium levels (2.83 vs 1.98 mEq/L, p = 0.025) compared to other drug types.

Patients who developed elevated levels had slightly higher baseline magnesium (1.78 vs 1.60 mEq/L, p = 0.041).

Related Experiment Videos

Main Methods:

The study used a prospective, non-randomized design with 24 participants. Patients were divided into single and multiple dose groups. Serum magnesium levels were measured before each dose. Blood samples were taken 1 and 4 hours after the final dose. The single dose group received 30 grams of magnesium sulfate once. The multiple dose group received three 30-gram doses at intervals. Baseline and peak levels were compared between groups. Drug type was noted to assess any interaction effects.

Main Results:

Single dose patients showed no significant change in magnesium levels. Only two out of ten had slightly elevated levels post-dose. In contrast, multiple dose patients had significantly higher levels after the second dose. Nine out of fourteen developed elevated magnesium levels. Peak levels in the multiple dose group reached up to 5.0 mEq/L. These levels were significantly higher than baseline (p = 0.004). Patients with hypermagnesemia had normal renal function markers. Those with anticholinergic or opioid ingestions had higher peak levels (2.83 vs 1.98, p = 0.025). Baseline magnesium levels were slightly higher in hypermagnesemia cases (1.78 vs 1.60, p = 0.041).

Conclusions:

The authors state that multiple-dose magnesium cathartics can cause rapid hypermagnesemia. This occurs even in patients with normal renal function. The study suggests that repeated doses increase magnesium levels significantly. The findings imply a need for caution in multi-dose protocols. The authors propose that drug type may influence magnesium retention. They note that baseline levels may predict hypermagnesemia risk. The study does not claim that single doses are unsafe. The authors emphasize the importance of monitoring after repeated cathartic use.

No, all patients with elevated levels had normal BUN and creatinine values.

The authors propose that repeated doses can cause rapid hypermagnesemia even in patients with normal renal function.